Crossref
Spironolactone in the Management of Congestive Heart Failure
Progress in Cardiovascular Nursing · 2000
DOI: 10.1111/j.0889-7204.2000.080403.x ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Cardiovascular Nursing, 2000. Verfasst von S R Kayser. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA. Die Arbeit nennt 7 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
DiureticsHeart FailureHumansMineralocorticoid Receptor AntagonistsPractice Guidelines as TopicRandomized Controlled Trials as TopicSpironolactoneTreatment Outcome
Substanzen
DiureticsMineralocorticoid Receptor AntagonistsSpironolactone
Autor:innen und Institutionen
- Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA.
Zitieren
APA
Kayser, S. R. (2000). Spironolactone in the Management of Congestive Heart Failure. Progress in Cardiovascular Nursing. https://doi.org/10.1111/j.0889-7204.2000.080403.x
Vancouver
Kayser SR. Spironolactone in the Management of Congestive Heart Failure. Progress in Cardiovascular Nursing. 2000. doi:10.1111/j.0889-7204.2000.080403.x
BibTeX
@article{Kayser2000,
author = {Kayser, S R},
title = {Spironolactone in the Management of Congestive Heart Failure},
journal = {Progress in Cardiovascular Nursing},
year = {2000},
doi = {10.1111/j.0889-7204.2000.080403.x}
}
EUVIMED